|
|

As a student and then as a clinician, prevention became the nucleus of Dr. Vogt’s research career. His work has investigated improving prevention services in the medical care setting, the quality and costs of preventive care, primary care organization, and satisfaction with care across several states and multiple managed care systems. He has also studied the relation of personality to disease risk, cardiovascular disease, osteoporosis, and cancer in devising targeted approaches to reduce or prevent these diseases. Recently, he has examined ways to improve the effectiveness and reduce the costs of preventive care in primary care settings to free up resources for needed care and additional preventive services. Continuing his long history of prevention research, his current research is helping worksites, which have no experience implementing health care programs, to launch and operate a worksite obesity management program and then studying the effects on weight and other health measures.
Dr. Vogt received his medical degree from the University of California, San Francisco, and an MS in public health from the University of California, at Berkeley. He began his research career as associate director of the San Francisco clinical center for the Multiple Risk Factor Intervention Trial (MRFIT). Subsequently, he was assistant professor of public health at the University of California, Los Angeles. In 1978, he joined CHR where he served in various capacities: as medical director of Portland's MRFIT clinical center and as head of several multi-center trials including the Systolic Hypertension in the Elderly Program, the Study of Osteorporotic Fractures, the Trials of Hypertension Prevention, and two National Cancer Institute projects focused on cancer control in the medical care setting. He was the principal investigator for the coordinating center of the Dietary Approach to Stop Hypertension study, a national clinical trial that marked the first time a dietary pattern, rather than a single nutrient such as sodium or calcium, was tested to prevent or control high blood pressure.
From 1989 to 1997, Dr. Vogt directed CHR's epidemiology and disease prevention program in Portland before leaving to join the faculty of the Cancer Research Center at the University of Hawaii. He returned to CHR in 1999 to become the director of CHR's new Hawaii program. He stepped down from that role in 2007.
Current Studies:
Recently Completed Studies:
E-mail: Tom.M.Vogt@kp.org
|